WHO WE ARE ?
Ixtlan Bioscience Inc. is an Israeli based biotech company bringing nature and innovation to diagnosed mental health and major depression patients, utilizing proprietary growing, extraction and formulation capabilities to create a portfolio of compounds derived from natural psilocybin mushrooms.
Affecting positive large scale change in the mental health field by focusing on novel and safe drug treatment protocols that address core issues and not solely symptom suppression.
Developing cutting edge growing methodologies, extraction protocols, and innovative preclinical assays to create unique proprietary formulations for clinical stage trials; correspondingly addressing patient safety by mitigating the risk of adverse effects possible from psilocin ingestion.
FROM PRECLINICAL DEVELOPMENT
TO CLINICAL VALIDATION
Creating naturally derived psilocybin formulations for the mental
health industry by controlling the process from spore production to diverse compound extractions.